
After a year of hesitation in the face of pending cost control guidelines, Vertex Pharmaceuticals has submitted Trikafta to Health Canada for approval - now the hard work begins, writes Jeremie Saunders.
from CBC | Canada News https://ift.tt/3nMgfAf
0 comments:
Post a Comment